The complement decay-acceleratingfactor (CD55), known to be highlyexpressed in the tumor environment and to play a role in the suppressionof adaptive immune responses,, was significantly up-regulatedin the control tissue of nonresponders (Figure C). The gene discussed is CD55; the disease is neoplasm.